能動埋め込み型医療機器の世界市場予測（～2022）：埋め込み型除細動器、心臓ペースメーカー、人工心臓、神経刺激器、埋め込み型助聴器...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Approach
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 28)

4 Premium Insights (Page No. – 31)
4.1 Active Implantable Medical Devices: Market Snapshot
4.2 Europe: Active Implantable Medical Devices Market, By Product
4.3 Active Implantable Medical Devices Market: Geographic Growth Opportunities
4.4 Active Implantable Medical Devices Market: Geographic Mix
4.5 Active Implantable Medical Devices Market: Developing vs Developed Countries/Regions

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Burden of Cardiovascular Diseases
5.2.1.2 Rising Prevalence of Neurological Disorders
5.2.1.3 Investments and Funds to Develop Technologically Advanced Products
5.2.1.4 Expanded Applications of Neurostimulators
5.2.1.5 Favorable Reimbursement Scenario for Ent Procedures in Developed Countries
5.2.2 Market Restraints
5.2.2.1 Unfavorable Healthcare Reforms in the U.S.
5.2.2.2 Issues Related to the Use of Implantable Medical Devices
5.2.2.3 High Cost of Implants and an Unfavorable Reimbursement Scenario
5.2.3 Market Opportunities
5.2.3.1 Emerging Markets Offer Significant Growth Opportunities
5.2.3.2 Development of Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
5.2.4 Market Challenges
5.2.4.1 Increasing Pricing Pressure on Market Players
5.2.4.2 Dearth of Skilled Professionals

6 Industry Insights (Page No. – 46)
6.1 Introduction
6.2 Key Industry Trends
6.2.1 Increasing Market Consolidation
6.2.2 Development of Innovative, Easy-To-Use Implantable Cardiovascular Products With Increased Longevity
6.2.3 Development of Technologically Advanced Implantable Hearing Devices and Expansion of Distribution Channel for Hearing Implants
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.3 Asia-Pacific
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
6.3.4 Rest of the World

7 Global Active Implantable Medical Devices Market, By Product (Page No. – 55)
7.1 Introduction
7.2 Implantable Cardioverter Defibrillators
7.2.1 Transvenous Implantable Cardioverter Defibrillators
7.2.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
7.2.1.2 Dual-Chamber Implantable Cardioverter Defibrillators
7.2.1.3 Single-Chamber Implantable Cardioverter Defibrillators
7.2.2 Subcutaneous Implantable Cardioverter Defibrillators
7.3 Implantable Cardiac Pacemakers
7.4 Ventricular Assist Devices
7.5 Implantable Heart Monitors/Insertable Loop Recorders
7.6 Neurostimulators
7.6.1 Spinal Cord Stimulators
7.6.2 Deep Brain Stimulators
7.6.3 Sacral Nerve Stimulators
7.6.4 Vagus Nerve Stimulators
7.6.5 Gastric Electrical Stimulators
7.7 Implantable Hearing Devices
7.7.1 Active Hearing Implants
7.7.2 Passive Hearing Implants

8 Global Active Implantable Medical Devices Market, By Region (Page No. – 87)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe (RoE)
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Asia-Pacific (Ro-APAC)
8.5 Latin America
8.6 Middle East and Africa

9 Competitive Landscape (Page No. – 156)
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Situations and Trends
9.3.1 Product Launches
9.3.2 Mergers & Acquisitions
9.3.3 Agreements, Partnerships, and Collaborations
9.3.4 Expansions

10 Company Profiles (Page No. – 167)
10.1 Introduction
(Overview, Products and Services, Financials, Strategy & Development)*
10.2 Abbott Laboratories
10.3 Medtronic PLC
10.4 Boston Scientific Corporation
10.5 Biotronik Se & Co., Kg
10.6 Livanova PLC
10.7 William Demant Holding A/S
10.8 Cochlear Limited
10.9 Sonova Holding AG
10.10 Med-EL
10.11 Nurotron Biotechnology Co. Ltd.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. – 190)
11.1 Insights of Industry Experts
11.2 Discussion Guide
11.3 Other Developments
11.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.5 Available Customizations
11.6 Introducing RT: Real-Time Market Intelligence
11.7 Related Reports
11.8 Author Details